of EZH2 protein were analyzed by immunoblotting T98G glioblastoma cells transfected with SC-shRNA, EZH2-shRNA, pJAX-SC or pJAX-EZH2. β-actin served as a loading control. (B) Relative deoxyglucose uptake was measured in T98G cells transfected with SC-shRNA, EZH2-shRNA, pJAX-SC or pJAX-EZH2. Each bar represents the mean ± s.d. from three independent experiments. *P < 0.05. (C) Enzymatic activities of HK2, PKM2 and PFK1 were determined in the indicated T98G cells. Each bar represents the mean ± s.d. from three independent experiments. *P < 0.05. (D) OCRs were determined using a Seahorse XF24 analyzer with T98G glioblastoma cells transfected with SC-shRNA or EZH2-shRNA. Oligomycin (1 mM) and FCCP (300 mM) were administered as indicated. (E) Basal OCR and Reserve Capacity were calculated in the U251 and T98G glioblastoma cells transduced with pJAX-SC or pJAX-EZH2. Data are presented as mean± s.d. from three independent experiments. (F) ECARs were determined using a Seahorse XF24 analyzer with T98G glioblastoma cells transfected with pJAX-SC or pJAX-EZH2. Oligomycin (1 mM) and FCCP (300 mM) were administered as indicated.

